Home › Melanoma › New York › Syracuse
Melanoma clinical trials in Syracuse, NY
3 studies for Melanoma are looking for participants at sites in and around Syracuse (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics
RecruitingObservational study
- State University of New York Upstate Medical University, Syracuse
- SUNY Upstate Medical Center Community Campus, Syracuse
Project: Every Child for Younger Patients With Cancer
RecruitingObservational study
- State University of New York Upstate Medical University, Syracuse
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Recruiting
- State University of New York Upstate Medical University, Syracuse
- State University of New York Upstate Medical Center-Community Campus, Syracuse
About Melanoma
Melanoma is the most serious type of skin cancer. Most have a black or black-blue area. Learn the 'ABCDE' of what to watch for and treatment options.
More about Melanoma on MedlinePlus
Melanoma trials in other cities
- Houston, TX61 studies
- New York City, NY41 studies
- Nashville, TN34 studies
- Los Angeles, CA34 studies
- Pittsburgh, PA31 studies
- Boston, MA25 studies
- St. Louis, MO23 studies
- Durham, NC22 studies
- Philadelphia, PA22 studies
- Tampa, FL21 studies
- Columbus, OH21 studies
- Dallas, TX21 studies
Other studies in Syracuse
- Non-Small Cell Lung Cancer16 studies
- Cancer (all types)9 studies
- Prostate Cancer9 studies
- Non-Muscle Invasive Bladder Cancer9 studies
- Ovarian Cancer7 studies
- Endometrial Cancer7 studies
- Colorectal Cancer6 studies
- Acute Myeloid Leukemia6 studies
- Type 2 Diabetes6 studies
- Obesity6 studies
- Lung Cancer6 studies
- Breast Cancer5 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.